NIT Rourkela develops cost-effective, label-free biosensor for breast cancer diagnosis 

The COVID-19 pandemic only served to compound these challenges by diverting medical supplies, postponing screenings as well as treatments. This serves to underscore the necessity for effective, accessible, and cost-efficient diagnostic technologies that are simple to deploy even in resource-scarce environments.

News